Verdad Advisers »

Upstream Bio shares owned by Verdad Advisers

Quarter-by-quarter ownership of Upstream Bio (UPB) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Upstream Bio

Tip: Access up to 7 years of quarterly data

All positions including Upstream Bio held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Upstream Bio by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $151k 22k 6.92

More positions owned by Verdad Advisers

Apple (AAPL)
Belite Bio Sponsored Ads (BLTE)
ACADIA Pharmaceuticals (ACAD)
Comcast Corp Cl A (CMCSA)
Chatham Lodging Trust (CLDT)
Tenax Therapeutics Com New (TENX)
Slide Ins Hldgs (SLDE)
Zymeworks Del (ZYME)
AMN Healthcare Services (AMN)
X4 Pharmaceuticals Com New (XFOR)
Versant Media Group Com Cl A (VSNT)
NetScout Systems (NTCT)
Aadi Bioscience (WHWK)
Johnson & Johnson (JNJ)
Contineum Therapeutics Cl A (CTNM)

View all positions for Verdad Advisers

Top funds holding Upstream Bio

FMR
OrbiMed Advisors
Norges Bank Investment Management
BlackRock
Decheng Capital
Enavate Sciences GP
Vanguard Capital Management
Millennium Management
D. E. Shaw & Co
Jpmorgan Chase & Co
Qube Research & Technologies
Parkman Healthcare Partners
Geode Capital Management
SEB Asset Management AB
Woodline Partners

View all funds holding Upstream Bio